| Literature DB >> 23705929 |
Chaowei Zhou1, Jie Zhang, Jideng Ma, Anan Jiang, Guoqing Tang, Miaomiao Mai, Li Zhu, Lin Bai, Mingzhou Li, Xuewei Li.
Abstract
BACKGROUND: The excessive accumulation of body fat is a major risk factor to develop a variety of metabolic diseases. To investigate the systematic association between the differences in gene expression profiling and adipose deposition, we used pig as a model, and measured the gene expression profiling of six variant adipose tissues in male and females from three pig breeds which display distinct fat level.Entities:
Mesh:
Year: 2013 PMID: 23705929 PMCID: PMC3679871 DOI: 10.1186/1476-511X-12-75
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Figure 1Identification and the PCA of the DE genes. (A) DE genes across breeds, sexes, and tissues; Two-way PCA of (B) six adipose tissues; (C) three pig breeds; (D) sexes. L, R and T refer to the Landrace, Rongchang and Tibetan, respectively.
Figure 2Identification of up- and down-regulated genes. L, R and T refer to the Landrace, Rongchang and Tibetan pig, respectively. SAT: subcutaneous adipose tissue; VAT: visceral adipose tissue.
Identification of DE genes which specifically up-regulated in SAT and VAT groups
| ULB VS. GOM | 298 | 378 |
| ULB VS. MAD | 304 | 291 |
| ULB VS. RAD | 164 | 142 |
| ULB VS. IAD | 154 | 163 |
| ILB VS. GOM | 286 | 302 |
| ILB VS. MAD | 260 | 222 |
| ILB VS. RAD | 73 | 60 |
| ILB VS. IAD | 84 | 119 |
| Specific expression genes | 192 (>4) * | 181 (>4) * |
*: if a DE gene were identified from at least four comparisons, which been termed as the tissue- specific DE gene.
Figure 3Top ten GO (Gene Ontology) terms enriched for the up- and down-regulated genes between the SATs and VATs. The p values indicated the significance of the comparison, was calculated by Benjamini-corrected modified Fisher’s exact test.
Figure 4Differences in mRNA expression levels of the and gene between the VATs and SATs.
Figure 5Top ten GO (Gene Ontology) terms enriched for the up- and down-regulated genes among the three pig breeds. (A) The Landrace versus Rongchang pig; (B) The Landrace versus Tibetan pig; (C) The Rongchang versus Tibetan pigs. The P values indicated the significance of the comparison, was calculated by Benjamini-corrected modified Fisher’s exact test.
Figure 6Top ten GO (Gene Ontology) terms enriched for the up- and down-regulated genes between the male and female pig breeds. The p values indicated the significance of the comparison, was calculated by Benjamini-corrected modified Fisher’s exact test.
Figure 7Differences in mRNA expression levels of the and gene between the between the females and males.
Figure 8Validation of gene expression by Q-PCR. The Pearson correlation coefficient (r) and the corresponding significance value (P) were shown above the columns.
Figure 9Heat maps of co-expressed gene modules in six adipose tissues. Two SATs (ILB: inner layer of backfat, ULB: upper layer of backfat); three VATs (GOM: greater omentum, MAD: mesenteric adipose, RAD: retroperitoneal adipose); and intermuscular adipose (IAD). Pair-wise correlations between genes residing in all the gene sets were plotted. Bright red indicates a strong positive co-expression, whereas bright green indicates strong negative co-expression.
Figure 10Correlations between co-expressed gene modules in six adipose tissues and obesity phenotypic traits. -Log10 P values for Spearman rank correlation coefficients between the expressed values of the gene modules and the different obesity phenotypic traits are shown. The gray line represents the Bonferroni corrected P value greater than 0.05.
Modules correlated with the obesity-related traits in SATs and VATs
| 4 | Adipocyte volume | 110 | −0.85 | 8.12 × 10-6 | ||
| 6 | LDH | 72 | −0.84 | 1.23 × 10-5 | ||
| 2 | Adipocyte volume | 157 | 0.87 | 2.05 × 10-6 | ||
| 2 | PAI-1 | 162 | −0.81 | 4.97 × 10-5 | ||
| 3 | IL-6 | 92 | −0.80 | 6.28 × 10-5 | ||
| 2 | TNF-a | 152 | 0.82 | 2.57 × 10-5 | ||
| 8 | Body density | 71 | 0.87 | 2.97 × 10-6 | ||
| 11 | Body density | 51 | −0.81 | 5.44 × 10-5 | ||
| 1 | HDL | 590 | 0.85 | 7.42 × 10-6 | ||
| 11 | Apo-A1 | 51 | −0.81 | 3.91 × 10-5 | ||
| 3 | Insulin | 118 | 0.77 | 6.89 × 10-6 | ||
| 10 | Body density | 55 | 0.86 | 5.90 × 10-6 | ||
| 11 | TNF-a | 52 | −0.83 | 2.15 × 10-5 | ||
Top ten GO (Gene Ontology) and pathway categories enriched for co-expressed gene modules which correlated with obesity phenotypic traits
| ULB (4) | GO-BP | metabolic process | 1.19 × 10-7 | 119 | |
| ILB (2) | GO-BP | coenzyme metabolic process | 8.84 × 10-6 | 8 | |
| GO-BP | lipid metabolic process | 4.38 × 10-5 | 23 | ||
| GO-BP | fatty acid metabolic process | 8.95 × 10-5 | 10 | ||
| GO-BP | primary metabolic process | 1.07 × 10-4 | 104 | ||
| GO-BP | translation | 5.37 × 10-4 | 12 | ||
| GO-BP | protein folding | 1.50 × 10-3 | 8 | ||
| GO-BP | fatty acid beta-oxidation | 2.65 × 10-3 | 3 | ||
| GO-BP | pentose-phosphate shunt | 3.51 × 10-3 | 2 | ||
| GO-BP | generation of precursor metabolites and energy | 4.15 × 10-3 | 9 | ||
| RAD (8,11) | GO-BP | translation | 1.44 × 10-3 | 8 | |
| IAD (10) | GO-BP | protein targeting | 1.90 × 10-3 | 5 | |
| GO-BP | lysosomal transport | 5.44 × 10-3 | 2 | ||
| GO-MF | structural constituent of ribosome | 6.10 × 10-3 | 5 | ||
| GO-MF | structural molecule activity | 6.62 × 10-3 | 15 | ||
| GO-BP | nitrogen utilization | 1.20 × 10-2 | 1 | ||
| KEGG | Serine glycine biosynthesis | 2.97 × 10-2 | 1 | ||
| GO-BP | regulation of amino acid metabolic process | 3.55 × 10-2 | 1 | ||
| GO-BP | pyrimidine base metabolic process | 4.40 × 10-2 | 2 | ||
| GO-BP | pentose-phosphate shunt | 4.71 × 10-2 | 1 | ||
| RAD (11) | GO-BP | nitrogen utilization | 3.51 × 10-3 | 1 | |
| GO-BP | regulation of amino acid metabolic process | 1.05 × 10-2 | 1 | ||
| GO-BP | lysosomal transport | 3.12 × 10-2 | 1 | ||
| GO-BP | nitrogen compound metabolic process | 3.12 × 10-2 | 1 | ||
| GO-BP | neuromuscular synaptic transmission | 4.64 × 10-2 | 1 | ||
| GO-MF | hormone activity | 1.55 × 10-2 | 2 | ||
| KEGG | Vasopressin synthesis | 2.09 × 10-2 | 1 | ||
| KEGG | De novo pyrmidineribonucleotidesbiosythesis | 3.12 × 10-2 | 1 | ||
| KEGG | Cortocotropin releasing factor receptor signaling pathway | 5.14 × 10-2 | 1 | ||
| KEGG | De novo purine biosynthesis | 5.64 × 10-2 | 1 | ||
| RAD (1) | GO-BP | generation of precursor metabolites and energy | 1.20 × 10-15 | 37 | |
| GO-BP | metabolic process | 1.49 × 10-14 | 273 | ||
| GO-BP | respiratory electron transport chain | 1.35 × 10-11 | 30 | ||
| GO-BP | coenzyme metabolic process | 3.02 × 10-9 | 16 | ||
| GO-BP | primary metabolic process | 9.31 × 10-9 | 241 | ||
| GO-BP | signal transduction | 6.95 × 10-7 | 48 | ||
| GO-BP | cell communication | 8.92 × 10-7 | 52 | ||
| GO-BP | cell surface receptor linked signal transduction | 1.49 × 10-6 | 15 | ||
| GO-BP | system development | 3.58 × 10-6 | 9 | ||
| GO-BP | tricarboxylic acid cycle | 5.49 × 10-6 | 7 | ||
| ULB (3) | GO-BP | fatty acid metabolic process | 1.37 × 10-5 | 9 | |
| GO-BP | metabolic process | 1.86 × 10-5 | 75 | ||
| GO-BP | fatty acid beta-oxidation | 3.05 × 10-5 | 4 | ||
| GO-BP | coenzyme metabolic process | 4.77 × 10-5 | 6 | ||
| GO-BP | cellular amino acid biosynthetic process | 9.01 × 10-5 | 5 | ||
| GO-BP | cellular amino acid metabolic process | 1.05 × 10-4 | 9 | ||
| GO-BP | protein folding | 4.66 × 10-4 | 7 | ||
| GO-BP | pentose-phosphate shunt | 1.45 × 10-3 | 2 | ||
| GO-BP | primary metabolic process | 1.99 × 10-3 | 66 | ||
| GO-BP | carbohydrate metabolic process | 2.94 × 10-3 | 12 | ||
| RAD (3) | KEGG | VEGF signaling pathway | 3.72 × 10-4 | 4 | |
| GO-BP | transcription, RNA-dependent | 4.06 × 10-4 | 2 | ||
| GO-BP | cell communication | 6.62 × 10-4 | 31 | ||
| GO-BP | mesoderm development | 1.04 × 10-3 | 11 | ||
| GO-BP | cellular process | 1.10 × 10-3 | 40 | ||
| GO-BP | protein amino acid ADP-ribosylation | 1.11 × 10-3 | 2 | ||
| GO-BP | signal transduction | 1.37 × 10-3 | 29 | ||
| GO-BP | esicle-mediated transport | 1.69 × 10-3 | 11 | ||
| GO-BP | system development | 1.93 × 10-3 | 14 | ||
| GO-BP | cell surface receptor linked signal transduction | 4.81 × 10-3 | 16 | ||
| GOM (3) | GO-BP | immune system process | 6.66 × 10-4 | 21 | |
| IAD (11) | GO-BP | response to stimulus | 7.72 × 10-4 | 16 | |
| GO-BP | response to interferon-gamma | 2.08 × 10-3 | 4 | ||
| GO-BP | cellular defense response | 4.67 × 10-3 | 6 | ||
| GO-BP | immune response | 6.84 × 10-3 | 8 | ||
| GO-BP | DNA recombination | 1.06 × 10-2 | 3 | ||
| GO-BP | nitrogen utilization | 1.16 × 10-2 | 1 | ||
| GO-BP | gluconeogenesis | 1.35 × 10-2 | 2 | ||
| GO-BP | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.81 × 10-2 | 2 | ||
| KEGG | T cell activation | 1.84 × 10-2 | 4 | ||
| MAD (2) | GO-BP | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 4.26 × 10-5 | 4 | |
| | | GO-BP | antigen processing and presentation | 6.56 × 10-4 | 4 |
| KEGG | T cell activation | 1.37 × 10-3 | 4 | ||
| | | GO-BP | cellular defense response | 3.14 × 10-3 | 6 |
| | | GO-BP | immune system process | 8.14 × 10-3 | 17 |
| | | GO-BP | tRNAaminoacylation for protein translation | 2.18 × 10-2 | 2 |
| | | KEGG | 5-Hydroxytryptamine biosynthesis | 3.17 × 10-2 | 1 |
| | | KEGG | Mannose metabolism | 3.69 × 10-2 | 1 |
| | | GO-BF | establishment or maintenance of chromatin architecture | 3.85 × 10-2 | 4 |
| GOM(2) | GO-BP | immune system process | 6.00 × 10-15 | 41 | |
| GO-BP | response to stimulus | 6.31 × 10-15 | 30 | ||
| GO-BP | cellular defense response | 1.25 × 10-10 | 15 | ||
| GO-BP | immune response | 1.35 × 10-10 | 19 | ||
| GO-BP | B cell mediated immunity | 1.05 × 10-7 | 9 | ||
| GO-BP | natural killer cell activation | 4.17 × 10-6 | 7 | ||
| GO-BP | antigen processing and presentation | 6.62 × 10-6 | 6 | ||
| KEGG | T cell activation | 2.04 × 10-5 | 6 | ||
| GO-BP | cell surface receptor linked signal transduction | 1.52 × 10-4 | 23 | ||
| KEGG | Inflammation mediated by chemokine and cytokine signaling pathway | 3.11 × 10-4 | 8 |
In all tests, the unified set of co-expressed genes for different adipose depots correlated to an obesity phenotypic trait was compared with the whole known genes which were appointed as the background. P values indicating significance of the overlap between various genes sets, was calculated using Benjamini-corrected modified Fisher’s exact test. BP biological process, MF molecular function.
Primers used for the Q-PCR assay
| F: TCTGGCACCACACCTTCT | 114 | DQ178122 | |
| | R: TGATCTGGGTCATCTTCTCAC | | |
| F: GATGGACGTTCGGTTTAGG | 124 | DQ178129 | |
| | R: AGCAGCACAGTACGAGCAA | | |
| F: AACTGGATGATGCTAATGATGCT | 137 | AF222921 | |
| | R: TGGAAAAACTCCGTATCTGTCTC | | |
| F: GTAAGAACAAATGCCAAGA | 103 | NM_213897 | |
| | R: CAGCCACTACAATCACAAC | | |
| F: GGGTCACTGTCCCTAAC | 209 | NM_214370 | |
| | R: GTCCTGGTACTGGTCGT | | |
| F: TGGCTGAAGGACAACGAC | 228 | NM_001007193 | |
| | R: CAAGAAGAACATCCCAAACAC | | |
| F: GCATCAGCCATATCTACTCACT | 107 | NM_001037149 | |
| | R: CACTTCTTTCCGCAGCAT | | |
| F: TAAGGTTATCGTGGTGGG | 124 | U44846 | |
| | R: TGCTTTAGCTCGGTTGTG | | |
| F: CGAGGTGGTCAAGGCTAAG | 172 | M16427 | |
| | R: CAATGGCGTGGAGAAATAC | | |
| F: GTTGCCCTTGGTGTTGT | 212 | X93016 | |
| | R: GGATAAATGGTGGCTGTC | | |
| F: TCAACCACGCCAGTGCTAA | 251 | AY336601.2 | |
| | R: CACGCCTCCCGAGAAGAAA | | |
| F: CGCCTGAAACAGAAATCG | 213 | XM_001924223 | |
| R: TCTCCTGAGCCTCCAACA |
*: ACTB (β actin), TBcP (TATA box binding protein) and TOP2B (topoisomerase II β) are the endogenous control genes.